Skip to main
RNAC
RNAC logo

RNAC Market Capitalization Overview

Market Cap: $270.45M as of Jun 13, 2025

$270.45M
Past Month-$259.50K (0.10%)
As of Jun 13, 2025, RNAC has a market capitalization of $270.45M. Over the past 30 days, its market cap has decreased by -18.61%, while in the last 12 months, it has decreased by -41.3%.

Market capitalization represents the total value of Cartesian Therapeutics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

RNAC Market Cap Formula = Stock Price * Shares Outstanding

The market cap of RNAC helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

RNAC Market Cap History

DateMarket CapChange
Jun 2, 2025$259.03M-18.61%
May 1, 2025$318.25M-1.65%
Apr 1, 2025$323.58M-28.12%
Mar 3, 2025$450.20M-12.02%
Feb 3, 2025$511.68M+17.48%
Jan 2, 2025$435.53M-12.43%

RNAC End of Year Market Cap History

DateMarket CapChange
2025$270.45M-41.30%
2024$460.75M+331.58%
2023$106.76M+23.47%
2022$86.47M-57.09%
2021$201.51M+23.07%
2020$163.73M

FAQs About Cartesian Therapeutics Inc (RNAC) Market Cap

As of Jun 13, 2025, the market capitalization of RNAC is $270.45M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Cartesian Therapeutics Inc’s market capitalization has decreased by -0.1000%, changing from $270.71M to $270.45M as of Jun 13, 2025.

In the last 3 months, Cartesian Therapeutics Inc’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Cartesian Therapeutics Inc’s market capitalization increased from $106.76M in January to $460.75M in December, reflecting a 331.58% change.

In the past five years, RNAC has had a compound annual growth rate (CAGR) of 22.99% in market capitalization. This means its market cap has grown at an average rate of 22.99% per year.

Cartesian Therapeutics Inc (RNAC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.